High protein diets may lead to long-term kidney damage among those suffering from chronic chronic kidney disease, according to research led by nephrologist Kamyar Kalantar-Zadeh, MD, MPH, PhD, of the University of California, Irvine.
CU Cancer Center study examines current RECIST guidelines in an effort to bring them up to speed with new complexities presented by the latest targeted therapies.
ASTRO Chair Brian Kavanagh, MD, MPH, FASTRO, will join representatives from leading physician groups Wednesday morning to discuss Medicare payment reform before the House Energy and Commerce Subcommittee on Health. The hearing, “MACRA and Alternative Payment Models: Developing Options for Value-based Care,” will focus on moving the U.S. health system from volume-based to value-based care through effective Medicare payment reform, namely the expansion of alternative payment models (APMs) for physician reimbursement.
The reward center of the brain is much more attuned to the pleasurable effects of alcohol when estrogen levels are elevated, an effect that may underlie the development of addiction in women, according to a study on mice at the University of Illinois at Chicago.
The Tisch Cancer Institute and the Precision Immunology Institute at Mount Sinai Health System are part of a $215 million public-private Cancer Moonshot research collaboration launched by the National Institutes of Health and 11 leading pharmaceutical companies.
As research increasingly links environmental factors with chronic disease, Hackensack Meridian Health Riverview Medical Center has enrolled in the Healthier Hospitals Initiative (HHI), a national campaign that supports hospitals in accelerating the greening of health care and reducing environmental impact. The initiative helps hospitals adopt sustainability efforts that will promote the health and well-being of patients, team members, and members of the community.
A research team led by scientists at the Krembil Research Institute in Toronto has identified a new neuroprotective factor that has the potential to help people suffering from the common blinding disease glaucoma.
New research from The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai, suggests that the capabilities of microfinance networks expand well beyond banking, and that tapping into these networks can bring measurable health improvements to rural and underserved communities on a national scale with reduced cost.
The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver disease.
Ludwig Cancer Research has released the scope of its participation at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting in National Harbor, Maryland, November 8-12.
Researchers from the University of Maryland, Baltimore and the University of Maastricht deomonstrated their ability to use mass spectrometry imaging (MSI) in tracking disease progression, opening avenues for future research into the applicability of MSI for disease studies and the development of therapeutics that target lipids to treat infection.
The below average efficacy of last year’s influenza vaccine (which was only 20 to 30 percent effective) can be attributed to a mutation in the H3N2 strain, a new study reports. With the mutation, most people receiving the egg-grown vaccine did not have immunity against H3N2 viruses that circulated last year.
Stony Brook University is part of a national five-year $8 million grant from the National Cancer Institute (NCI) to develop a testbed for using data analytics and radiology and pathology images to better steer cancer treatment.
eople with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent findings published by researchers at Huntsman Cancer Institute at the University of Utah identified a promising prevention treatment for patients with FAP.
More than half of the babies with infantile-onset spinal muscular atrophy (SMA) who were treated with nusinersen (Spinraza) gained motor milestones, compared to none of the babies in the control group. Infants treated with the drug also had 63 percent lower risk of death. These final results from the 13-month, international, randomized, multicenter, sham procedure-controlled, phase 3 trial called ENDEAR were published in the New England Journal of Medicine.
Scientists have not been able to describe how light moves within nontransparent scintillators – a key component in large area x-ray detectors. Now a new study describes how this light moves, a finding that may help to improve medical imaging.
ISPOR, the professional society for health economics and outcomes research, held several sessions on the topic of orphan drugs at its 20th Annual European Congress, currently being held 4-8 November 2017 in Glasgow, Scotland, UK.
A free telephone support and education program for people with lupus is a valuable resource to help them cope with the disease, according to a study at Hospital for Special Surgery (HSS) in New York City.
ISPOR, the professional society for health economics and outcomes research, held a session this afternoon at its 20th Annual European Congress in Glasgow, Scotland, UK that explored the question, “what is ‘unmet medical need?’”
A new study shows that a 70-year-old malaria drug can block immune cells in the liver so nanoparticles can arrive at their intended tumor site, overcoming a significant hurdle of targeted drug delivery, according to a team of researchers led by Houston Methodist.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right